A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's antiplatelet effects in patients undergoing urgent surgery or experiencing major ...

A BLA has been filed for bentracimab and, if approved, has the potential to be the first therapy to reverse the effects of Brilinta for patients who have bleeding events or who need urgent surgery.

Background: Dual antiplatelet therapy is the standard of care for acute coronary syndrome, but uncertainty exists regarding ...

"A patient on ticagrelor who needs emergency heart surgery is at high risk for developing serious bleeding during the surgery," he said. "If you delay the surgery, there's a risk the patient could ...

The FDA has granted a fast review of AstraZeneca’s cardiovascular diseases drug Brilinta (ticagrelor) in the new indication that aims to reduce the chances of patients having recurring strokes.

A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor’s antiplatelet effects in patients undergoing urgent surgery or experiencing major ...

An investigational monoclonal antibody called bentracimab can safely and effectively reverse potentially catastrophic ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

In patients with acute coronary syndrome (ACS), coronary artery bypass graft (CABG) surgery performed 2-3 days after ticagrelor cessation showed noninferiority with respect to perioperative ...

Neuroscientists have observed for the first time how structures deep in the brain are activated when the brain becomes aware of its own thoughts, known as conscious perception 1. The brain is ...

Effient is often taken along with aspirin. Effient is available in tablet form to be taken by mouth. It comes in strengths of 5 mg and 10 mg. Ticagrelor, more commonly known by its brand name, ...